Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.

Source:http://linkedlifedata.com/resource/pubmed/id/3313041

N. Engl. J. Med. 1987 Nov 12 317 20 1237-45

Download in:

View as

Triples

General Info

PMID
3313041